In pancreatic cancer, mutations occur during tumorigenesis, in particular in the Kirsten rat sarcoma viral oncogene homologue (KRAS) oncogene, increasing the activity of this protein [159,160,161,162]. Here, KRAS is linked to pancreatic neoplasm.